Skip to main content

News Archive

News Archive - Miles Martin

Eight UC San Diego Researchers Elected 2025 AAAS Fellows

March 26, 2026

Eight researchers at the University of California San Diego have been elected 2025 Fellows of the American Association for the Advancement of Science (AAAS): Andrew D. Chisholm, Farinaz Koushanfar, Albert P. Pisano, Ravi Ramamoorthi, JoAnn Trejo, Emily Troemel, Meenakshi Wadhwa and Sheng Zhong.

How One Receptor Can Help — or Hurt — Your Blood Vessels

March 10, 2026

A single receptor in blood vessels can trigger either harmful inflammation or protective healing, but scientists have struggled to understand how this is possible. UC San Diego research has now answered this outstanding question.

Long-Read Genome Sequencing Uncovers New Autism Gene Variants

March 9, 2026

By utilizing long-read sequencing, an emerging technique that reads large sections of the genome at once, scientists at UC San Diego have revealed new genetic variants associated with autism spectrum disorder.

Rewiring Immune System Offers New Path to Better Ovarian Cancer Treatment

March 5, 2026

A new discovery from UC San Diego researchers could enable easier treatment of high-grade serous ovarian cancer, the most common and aggressive form of ovarian cancer.

Team Led by UC San Diego Researchers Selected for Prestigious Global Cancer Prize

March 4, 2026

With up to $25 million from Cancer Grand Challenges, an international team led by UC San Diego professor Ludmil Alexandrov will unlock the secrets of DNA's "fingerprints."

Six UC San Diego Faculty Elected to National Academy of Inventors for 2026

February 26, 2026

Six professors from the University of California San Diego have been named Senior Members of the National Academy of Inventors (NAI) in recognition of their outstanding achievements in innovation, from controlling populations of disease-spreading insects to turning smartphones into health monitors.

Airborne Toxins Trigger a Unique Form of Chronic Sinus Disease in Veterans

February 11, 2026

UC San Diego study reveals that toxin‑related chronic rhinosinusitis shows a two‑fold rise in sinus mast cells, pointing to a new therapeutic target for veterans and others exposed to smoke airway risk factor.

Immunity Against Common Virus Leveraged Against Pancreatic Cancer

February 9, 2026

UC San Diego researchers have harnessed the body's immune response to a common virus to shrink pancreatic tumors, offering hope for a new cancer treatment approach.

Blueprints for Designing T Cells that Kill

February 4, 2026

By mapping the varied states of our body's immune cells, UC San Diego researchers are working to empower the next generation of cancer immunotherapies.

Mentorship, Empathy, and the Art of Medicine: UC San Diego’s Mentor Clinician Program

January 13, 2026

Over the last decade, the Mentor Clinician Program Program at the UC San Diego School of Medicine has quietly transformed how tomorrow’s physicians learn, grow and connect with their patients.
Category navigation with Social links